Prevalence and predictors of poor heart failure treatment outcomes in Ethiopia: a systematic review and meta-analysis
2024

Heart Failure Treatment Outcomes in Ethiopia

Sample size: 3002 publication Evidence: moderate

Author Information

Author(s): Bekele Firomsa, Tafese Lalise, Fekadu Ginenus, Dube Geleta Nenko, Dugassa Dinka, Samuel Dagim

Primary Institution: Wallaga University, Nekemte, Ethiopia

Hypothesis

What are the prevalence and predictors of poor heart failure treatment outcomes in Ethiopia?

Conclusion

The prevalence of poor heart failure treatment outcomes in Ethiopia is high, with smoking and medication-related problems being significant predictors.

Supporting Evidence

  • The pooled prevalence of poor heart failure treatment outcomes was found to be 16.67%.
  • Smoking cigarettes was associated with a 10.74 times higher likelihood of poor treatment outcomes.
  • Medication-related problems increased the likelihood of poor treatment outcomes by 3.99 times.

Takeaway

Many people in Ethiopia with heart failure are not getting better, especially if they smoke or have problems with their medications.

Methodology

A systematic review and meta-analysis of 12 studies using five databases.

Potential Biases

Potential for publication bias as studies with negative results may be less likely to be published.

Limitations

The included studies varied in design and quality, which may affect the generalizability of the findings.

Participant Demographics

The majority of participants were female, with a total sample size of 3002 patients.

Statistical Information

P-Value

0.962

Confidence Interval

95% CI: 10.67–22.67

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fcvm.2024.1434265

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication